Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statins as cellular antithrombotics.

J W Fenton1, G X Shen

  • 1New York State Department of Health, Wadsworth Center, Albany, NY 12201-0509, USA.

Haemostasis
|January 12, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sudden-onset unilateral ptosis induced by pituitary Macroadenoma, with false-positive jolly and neostigmine tests.

Journal of biological regulators and homeostatic agents·2018
Same author

Development of composite outcomes for individual patient data (IPD) meta-analysis on the effects of diet and lifestyle in pregnancy: a Delphi survey.

BJOG : an international journal of obstetrics and gynaecology·2016
Same author

Physical activity intensity and type 2 diabetes risk in overweight youth: a randomized trial.

International journal of obesity (2005)·2015
Same author

Does First Nations ancestry modify the association between gestational diabetes and subsequent diabetes: a historical prospective cohort study among women in Manitoba, Canada.

Diabetic medicine : a journal of the British Diabetic Association·2015
Same author

Effect of hirulog-like peptide on middle cerebral artery occlusion-induced brain injury in mice.

Neuroscience·2014
Same author

Expression of c-FLIP in malignant melanoma, and its relationship with the clinicopathological features of the disease.

Clinical and experimental dermatology·2011
Same journal

Thrombosis and Haemostasis Issues in Cancer. International Conference. Bergamo, Italy, 2-4 November 2001. Lectures and abstracts.

Haemostasis·2002
Same journal

Biochemistry of cancer procoagulant.

Haemostasis·2002
Same journal

Management of thromboembolic disease in cancer patients.

Haemostasis·2002
Same journal

An overview of thromboprophylaxis in malignancy.

Haemostasis·2002
Same journal

Platelets cross-talk with tumor cells.

Haemostasis·2002
Same journal

Properties and function of heparanase in cancer metastasis and angiogenesis.

Haemostasis·2002
See all related articles

Statins may prevent cardiovascular events by inhibiting thrombin generation at the cellular level, independent of cholesterol reduction. This suggests statins could be a new class of antithrombotics.

Area of Science:

  • Biochemistry
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Statins reduce cardiovascular disease, but the mechanism beyond cholesterol reduction is unclear.
  • Thrombin (IIa) is a key mediator of cardiovascular events, acting via protease-activated receptor-1 (PAR-1).
  • Statins inhibit the mevalonic acid pathway, affecting isoprenoid synthesis.

Purpose of the Study:

  • To investigate the potential antithrombotic mechanism of statins.
  • To explore the role of thrombin (IIa) and protease-activated receptor-1 (PAR-1) in statin action.
  • To hypothesize that statins downregulate thrombin generation, acting as antithrombotics.

Main Methods:

  • Review of existing literature on statin mechanisms and thrombin signaling.
  • Analysis of isoprenoid pathway interactions with PAR-1 activation.

Related Experiment Videos

  • Hypothesizing cellular mechanisms linking statins, PAR-1, and thrombin generation.

    • Main Results:

    • Statins inhibit an isoprenoid-dependent event between PAR-1 activation and tissue factor upregulation.
    • This inhibition occurs upstream of thrombin (IIa) generation.
    • Statins impact cell-regulating substances like ras proteins via PAR-1.

    Conclusions:

    • Statins may exert antithrombotic effects by downregulating thrombin (IIa) generation at the cellular level.
    • This mechanism is independent of statins' cholesterol-lowering effects.
    • Statins represent a potential novel class of antithrombotic agents.